EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Reply to: “The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient”

Matthew L Rizk iD, Sandra A G Visser iD

Clinical Pharmacology & Therapeutics · 2026-09 · 120 (3) · 586-586

DOI: 10.1002/cpt.70385 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 26.06.2026. Verfasst von Matthew L Rizk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Merck & Co., Inc., Rahway, New Jersey, USA. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Merck & Co., Inc., Rahway, New Jersey, USA.
  • Quantivis LLC, Lansdale, Pennsylvania, USA.

ORCID-Profile: Matthew L Rizk, Sandra A G Visser

Zitieren

APA

Rizk, M. L., & Visser, S. A. G. (2026). Reply to: “The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient”. Clinical Pharmacology & Therapeutics, 120(3), 586-586. https://doi.org/10.1002/cpt.70385

Vancouver

Rizk ML, Visser SAG. Reply to: “The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient”. Clinical Pharmacology & Therapeutics. 2026;120(3):586-586. doi:10.1002/cpt.70385

BibTeX
@article{Rizk2026,
  author = {Rizk, Matthew L and Visser, Sandra A G},
  title = {Reply to: “The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient”},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  volume = {120},
  number = {3},
  pages = {586--586},
  doi = {10.1002/cpt.70385}
}
Kostenlos starten →